Don't have a Account?
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
| Connect with us
Updated on 17 October 2013
Even as regulatory pressure grows within and outside India, large generic firms are laying stress on current good manufacturing practices (GMP) in order to avoid any compliance issues.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau
Your comment has been successfully added, and will be posted shortly. Thank you for your contribution!
Notify me of follow-up comments via e-mail address
India's Union Budget 2014
Was the Pharma Industry neglected in the Country's UNION BUDGET 2014?
Subscribe to BioSpectrum Asia
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
BioSpectrum Asia Newsletters
Sign up for the daily news from Asia bioscience industry
Asia Life Science Services Resource Guide
Asia Life Science Services Resource Guide is the first-of-its-kind Resource Guide, focused on providing information that you need for outsourcing the drug discovery and manufacturing process to Asia.
Copyright © 2014 MM ACTIV. All rights reserved.
Reproduction in whole or in part in any form or medium without written permission is prohibited.
Send this article by email